key: cord-0960763-k0te068l authors: Mao, Ren; Liang, Jie; Shen, Jun; Ghosh, Subrata; Zhu, Liang-Ru; Yang, Hong; Wu, Kai-Chun; Chen, Min-Hu title: Implications of COVID-19 for patients with pre-existing digestive diseases date: 2020-03-11 journal: Lancet Gastroenterol Hepatol DOI: 10.1016/s2468-1253(20)30076-5 sha: e1c4cb9955806b21950e45febde81d0eca3a5b3e doc_id: 960763 cord_uid: k0te068l nan C o V -2 仍 不 清 楚 。 在 最 近 中 国 癌 症 患 者 感 染 SARS-CoV-2的分析中 7 , 1590例COVID-19中有 18例(1%)有肿瘤史, 其中3例结直肠癌病史( 结肠管状腺癌1例,直肠癌1例,结直肠癌1例) 。 7 目前数据显示合并肿瘤的COVID-19的患者预 后更差。因此建议,在患者个体化治疗基础上推 迟辅助化疗或择期手术,加强个人防护措施,以 及更严密的监控或治疗。 7 生物制剂和免疫抑制剂的使用,是否使IBD患 者更易感染SARS-CoV-2是普遍关注的问题。目 前,在包括中国最 大的7个IBD转诊中心,拥有 表1. COVID- First case of 2019 novel coronavirus in the United States Clinical characteristics of coronavirus disease 2019 in China Macroscopic autopsy findings in a patient with COVID-19 Liver injury in COVID-19: management and challenges Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening COVID-19) for transplant clinicians Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Networked Clinical study collaboration on inflammatory bowel disease in China Chinse Society of IBD. Managing IBD patients during the outbreak of COVID-19 Crohn's Colitis Foundation. What IBD patients should know about the 2019 novel coronavirus Crohn's & Colitis UK. Novel coronavirus (COVID-19) advice